Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Muñoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A; GS-US-540-5773 Investigators. Goldman JD, et al. Among authors: montejano r. N Engl J Med. 2020 Nov 5;383(19):1827-1837. doi: 10.1056/NEJMoa2015301. Epub 2020 May 27. N Engl J Med. 2020. PMID: 32459919 Free PMC article. Clinical Trial.
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain.
Soriano A, Montejano R, Sanz-Moreno J, Figueira JC, Grau S, Güerri-Fernández R, Castro-Gómez A, Pérez-Román I, Hidalgo-Vega Á, González-Domínguez A. Soriano A, et al. Among authors: montejano r. Adv Ther. 2021 Jul;38(7):4057-4069. doi: 10.1007/s12325-021-01804-9. Epub 2021 Jun 12. Adv Ther. 2021. PMID: 34118007 Free PMC article.
Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians.
Esteban-Cantos A, Montejano R, Pinto-Martínez A, Rodríguez-Centeno J, Pulido F, Arribas JR. Esteban-Cantos A, et al. Among authors: montejano r. Lancet HIV. 2024 Apr 8:S2352-3018(24)00063-8. doi: 10.1016/S2352-3018(24)00063-8. Online ahead of print. Lancet HIV. 2024. PMID: 38604202 Review.
A safety evaluation of raltegravir for the treatment of HIV.
de Miguel R, Montejano R, Stella-Ascariz N, Arribas JR. de Miguel R, et al. Among authors: montejano r. Expert Opin Drug Saf. 2018 Feb;17(2):217-223. doi: 10.1080/14740338.2018.1411903. Epub 2017 Dec 5. Expert Opin Drug Saf. 2018. PMID: 29199485 Review.
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
Alonso-Navarro R, Ramírez M, Masiá M, Paredes R, Montejano R, Povar-Echeverria M, Carratalà J, Salavert M, Bernal E, Dueñas C, Flores J, Fanjul F, Gutiérrez I, Rico V, Mateu L, Cadiñanos J, Berenguer J, Soriano A. Alonso-Navarro R, et al. Among authors: montejano r. BMC Infect Dis. 2023 May 4;23(1):286. doi: 10.1186/s12879-023-08222-y. BMC Infect Dis. 2023. PMID: 37142994 Free PMC article.
Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV.
Ramos-Ruperto L, Arcos-Rueda MDM, de Miguel-Buckley R, Busca-Arenzana C, Mican R, Montejano R, Delgado-Hierro A, Montes ML, Valencia ME, Serrano L, Arribas JR, González J, Bernardino JI, Martín-Carbonero L. Ramos-Ruperto L, et al. Among authors: montejano r. HIV Med. 2024 Feb 20. doi: 10.1111/hiv.13617. Online ahead of print. HIV Med. 2024. PMID: 38379338
Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on the Telomere Length of Aviremic HIV-Infected Patients.
Montejano R, Stella-Ascariz N, Monge S, Bernardino JI, Pérez-Valero I, Montes ML, Valencia E, Martín-Carbonero L, Moreno V, González-García J, Arnalich F, Mingorance J, Pintado Berniches L, Perona R, Arribas JR. Montejano R, et al. J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):102-109. doi: 10.1097/QAI.0000000000001391. J Acquir Immune Defic Syndr. 2017. PMID: 28418989 Free article.
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.
Davey RT Jr, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, Neaton JD; INSIGHT FLU-IVIG Study Group. Davey RT Jr, et al. Lancet Respir Med. 2019 Nov;7(11):951-963. doi: 10.1016/S2213-2600(19)30253-X. Epub 2019 Sep 30. Lancet Respir Med. 2019. PMID: 31582358 Free PMC article. Clinical Trial.
76 results